Data provided by Nasdaq. Minimum 15 minutes delayed.
May 17, 2018
Nuvectra to Present at Two Upcoming Investor Conferences
PLANO, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences in June 2018. Event: Jefferies 2018 Global Healthcare Conference
May 02, 2018
Nuvectra™ Reports First Quarter 2018 Financial Results
PLANO, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2018. Highlights Reported consolidated revenues of $10.6 million for the first quarter 2018, including total Algovita® sales of $9.1 million. Expanded U.S. commercial team. Completed follow-on public offering of common stock for gross proceeds of approximately $26.0 million in February
The Ruth Group